PLx Pharma Inc. (PLXP): Don’t disregard this ominous signal – Invest Chronicle

PLx Pharma Inc. (PLXP): Don’t disregard this ominous signal

For the readers interested in the stock health of PLx Pharma Inc. (PLXP). It is currently valued at $2.03. When the transactions were called off in the previous session, Stock hit the highs of $2.36, after setting-off with the price of $2.30. Company’s stock value dipped to $1.925 during the trading on the day. When the trading was stopped its value was $2.37.Recently in News on April 22, 2022, PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update. PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORE 81 mg and VAZALORE 325 mg liquid-filled aspirin capsules (referred to together as “VAZALORE®”), today announced that it will release its 2022 first quarter financial results before the opening of the U.S. financial markets on Friday, May 13, 2022. Company executives will host a conference call at 8:30am ET that day with institutional investors and analysts to provide an overview of PLx Pharma’s performance for the quarter, along with a business update. You can read further details here

PLx Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $8.68 on 01/03/22, with the lowest value was $1.92 for the same time period, recorded on 05/12/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


PLx Pharma Inc. (PLXP) full year performance was -79.29%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, PLx Pharma Inc. shares are logging -90.56% during the 52-week period from high price, and -5.14% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.14 and $21.50.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 810609 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the PLx Pharma Inc. (PLXP) recorded performance in the market was -74.66%, having the revenues showcasing -68.53% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 58.79M, as it employees total of 16 workers.

Analysts verdict on PLx Pharma Inc. (PLXP)

During the last month, 0 analysts gave the PLx Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 5.08, with a change in the price was noted -6.59. In a similar fashion, PLx Pharma Inc. posted a movement of -76.45% for the period of last 100 days, recording 244,802 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PLXP is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

PLx Pharma Inc. (PLXP): Technical Analysis

Raw Stochastic average of PLx Pharma Inc. in the period of last 50 days is set at 3.13%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 5.43%. In the last 20 days, the company’s Stochastic %K was 6.89% and its Stochastic %D was recorded 4.96%.

Let’s take a glance in the erstwhile performances of PLx Pharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -74.66%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -83.76%, alongside a downfall of -79.29% for the period of the last 12 months. The shares increased approximately by -33.00% in the 7-day charts and went up by -39.76% in the period of the last 30 days. Common stock shares were lifted by -68.53% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts